ALXN Crosses Above Average Analyst Target
December 15, 2020 at 07:56 AM EST
In recent trading, shares of Alexion Pharmaceuticals Inc. (ALXN) have crossed above the average analyst 12-month target price of $145.88, changing hands for $156.31/share..
